Literature DB >> 16154429

Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes.

Mei-Ying Zhu1, Alyssa H Hasty, Carla Harris, Macrae F Linton, Sergio Fazio, Larry L Swift.   

Abstract

Studies in our laboratory have shown that a fraction of apolipoprotein (apo) E internalized by hepatocytes escapes degradation and is resecreted. Although the intracellular routing is not fully understood, our studies suggest that a portion of apoE recycles through the Golgi apparatus. Given the role of the Golgi apparatus in lipoprotein secretion and the fact that apoE modulates the hepatic secretion of very low-density lipoprotein, we hypothesized that recycling apoE has an effect on hepatic very low-density lipoprotein assembly and/or secretion. To test this hypothesis, apoE-/- mice were transplanted with bone marrow from wild-type mice. In this model, extrahepatic (macrophage-derived) apoE is internalized by the hepatocytes in vivo and is resecreted when the hepatocytes are placed in culture. Unexpectedly, our studies demonstrate that recycling apoE has little effect on hepatic lipid content or hepatocyte triglyceride secretion. In addition, recycling apoE has little effect on the expression of enzymes and proteins involved in lipid synthesis as well as plasma lipoprotein apoproteins. We conclude that the physiological relevance of apoE recycling may not be related to cell-specific functions, such as lipoprotein assembly in the liver. Rather, recycling may provide a mechanism for modulating general cellular effects such as intracellular cholesterol transport or cholesterol efflux.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154429     DOI: 10.1016/j.metabol.2005.04.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.

Authors:  Carol A Rouzer; Pavlina T Ivanova; Mark O Byrne; Stephen B Milne; Lawrence J Marnett; H Alex Brown
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

2.  Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Authors:  Hagai Tavori; Ilaria Giunzioni; Irene M Predazzi; Deanna Plubell; Anna Shivinsky; Joshua Miles; Rachel M Devay; Hong Liang; Shirya Rashid; MacRae F Linton; Sergio Fazio
Journal:  Cardiovasc Res       Date:  2016-03-15       Impact factor: 10.787

3.  Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks.

Authors:  Sarah K Knutson; Brenda J Chyla; Joseph M Amann; Srividya Bhaskara; Stacey S Huppert; Scott W Hiebert
Journal:  EMBO J       Date:  2008-03-20       Impact factor: 11.598

Review 4.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

5.  The effect of old age on apolipoprotein E and its receptors in rat liver.

Authors:  Tharani Sabaretnam; Jennifer O'Reilly; Leonard Kritharides; David G Le Couteur
Journal:  Age (Dordr)       Date:  2009-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.